Microarray expression analysis and identification of serum biomarkers for niemann-pick disease, type c1

Human Molecular Genetics

Volumn 21, Issue 16, 2012, Pages 3632-3646

  Cluzeau, Celine V M ^a   Watkins Chow, Dawn E ^b   Fu, Rao ^a,c   Borate, Bhavesh ^b   Yanjanin, Nicole ^a   Dail, Michelle K ^a   Davidson, Cristin D ^d   Walkley, Steven U ^d   Ory, Daniel S ^e   Wassif, Christopher A ^a   Pavan, William J ^b   Porter, Forbes D ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CATHEPSIN D; CYTOCHROME P450; GALECTIN 3; GUANINE NUCLEOTIDE BINDING PROTEIN; LIPID; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ADHESION; CELL CYCLE REGULATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DISEASE COURSE; DISEASE SEVERITY; DRUG METABOLISM; FEMALE; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LIPID METABOLISM; MALE; MICROARRAY ANALYSIS; MOUSE; NIEMANN PICK DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SCHOOL CHILD; SIGNAL TRANSDUCTION;

ADOLESCENT; AGE FACTORS; ANIMALS; BETA-CYCLODEXTRINS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CATHEPSIN D; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 ENZYME SYSTEM; DISEASE MODELS, ANIMAL; FEMALE; GALECTIN 3; HUMANS; INFANT; LIPID METABOLISM; LIVER; MALE; MICE; MICE, MUTANT STRAINS; MICROARRAY ANALYSIS; NIEMANN-PICK DISEASE, TYPE C; PROTEINS; SURVIVAL RATE; TRANSCRIPTOME;

EID: 84865066581     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds193     Document Type: Article

References (92)

1. Zervas, M., Dobrenis, K. and Walkley, S.U. (2001) Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. J. Neuropathol. Exp. Neurol., 60, 49-64.
2. Pentchev, P.G., Comly, M.E., Kruth, H.S., Tokoro, T., Butler, J., Sokol, J., Filling-Katz, M., Quirk, J.M., Marshall, D.C., Patel, S. et al. (1987) Group C Niemann-Pick disease: faulty regulation of low-density lipoprotein uptake and cholesterol storage in cultured fibroblasts. FASEB J., 1, 40-45.
3. Vanier, M.T. and Millat, G. (2003) Niemann-Pick disease type C. Clin. Genet., 64, 269-281.
4. Kelly, D.A., Portmann, B., Mowat, A.P., Sherlock, S. and Lake, B.D. (1993) Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. J. Pediatr., 123, 242-247.
5. Yerushalmi, B., Sokol, R.J., Narkewicz, M.R., Smith, D., Ashmead, J.W. and Wenger, D.A. (2002) Niemann-Pick disease type C in neonatal cholestasis at a North American Center. J. Pediatr. Gastroenterol. Nutr., 35, 44-50.
6. Carstea, E.D., Morris, J.A., Coleman, K.G., Loftus, S.K., Zhang, D., Cummings, C., Gu, J., Rosenfeld, M.A., Pavan, W.J., Krizman, D.B. et al. (1997) Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science, 277, 228-231.
7. Ory, D.S. (2004) The Niemann-Pick disease genes; regulators of cellular cholesterol homeostasis. Trends Cardiovasc. Med., 14, 66-72.
8. Greer, W.L., Riddell, D.C., Gillan, T.L., Girouard, G.S., Sparrow, S.M., Byers, D.M., Dobson, M.J. and Neumann, P.E. (1998) The Nova Scotia (type D) form of Niemann-Pick disease is caused by a G3097-T transversion in NPC1. Am. J. Hum. Genet., 63, 52-54.
9. Naureckiene, S., Sleat, D.E., Lackland, H., Fensom, A., Vanier, M.T., Wattiaux, R., Jadot, M. and Lobel, P. (2000) Identification of HE1 as the second gene of Niemann-Pick C disease. Science, 290, 2298-2301.
10. Friedland, N., Liou, H.L., Lobel, P. and Stock, A.M. (2003) Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 disease. Proc. Natl Acad. Sci. USA, 100, 2512-2517.
11. Kwon, H.J., Abi-Mosleh, L., Wang, M.L., Deisenhofer, J., Goldstein, J.L., Brown, M.S. and Infante, R.E. (2009) Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Cell, 137, 1213-1224.
12. Sleat, D.E., Wiseman, J.A., El-Banna, M., Price, S.M., Verot, L., Shen, M.M., Tint, G.S., Vanier, M.T., Walkley, S.U. and Lobel, P. (2004) Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport. Proc. Natl Acad. Sci. USA, 101, 5886-5891.
13. Infante, R.E., Wang, M.L., Radhakrishnan, A., Kwon, H.J., Brown, M.S. and Goldstein, J.L. (2008) NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes. Proc. Natl Acad. Sci. USA, 105, 15287-15292.
14. Morris, M.D., Bhuvaneswaran, C., Shio, H. and Fowler, S. (1982) Lysosome lipid storage disorder in NCTR-BALB/c mice. I. Description of the disease and genetics. Am. J. Pathol., 108, 140-149.
15. Beltroy, E.P., Liu, B., Dietschy, J.M. and Turley, S.D. (2007) Lysosomal unesterified cholesterol content correlates with liver cell death in murine Niemann-Pick type C disease. J. Lipid Res., 48, 869-881.
16. Beltroy, E.P., Richardson, J.A., Horton, J.D., Turley, S.D. and Dietschy, J.M. (2005) Cholesterol accumulation and liver cell death in mice with Niemann-Pick type C disease. Hepatology, 42, 886-893.
17. Garver, W.S., Jelinek, D., Oyarzo, J.N., Flynn, J., Zuckerman, M., Krishnan, K., Chung, B.H. and Heidenreich, R.A. (2007) Characterization of liver disease and lipid metabolism in the Niemann-Pick C1 mouse. J. Cell. Biochem., 101, 498-516.
18. Loftus, S.K., Erickson, R.P., Walkley, S.U., Bryant, M.A., Incao, A., Heidenreich, R.A. and Pavan, W.J. (2002) Rescue of neurodegeneration in Niemann-Pick C mice by a prion-promoter-driven Npc1 cDNA transgene. Hum. Mol. Genet., 11, 3107-3114.
19. Erickson, R.P., Bhattacharyya, A., Hunter, R.J., Heidenreich, R.A. and Cherrington, N.J. (2005) Liver disease with altered bile acid transport in Niemann-Pick C mice on a high-fat, 1% cholesterol diet. Am. J. Physiol. Gastrointest. Liver Physiol., 289, G300-G307.
20. Porter, F.D., Scherrer, D.E., Lanier, M.H., Langmade, S.J., Molugu, V., Gale, S.E., Olzeski, D., Sidhu, R., Dietzen, D.J., Fu, R. et al. (2010) Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci. Transl. Med., 2, 56ra81.
21. Jiang, X., Sidhu, R., Porter, F.D., Yanjanin, N.M., Speak, A.O., Te Vruchte, D.T., Platt, F.M., Fujiwara, H., Scherrer, D.E., Zhang, J. et al. (2011) A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma. J. Lipid Res., 52, 1435-1445.
22. Elrick, M.J., Pacheco, C.D., Yu, T., Dadgar, N., Shakkottai, V.G., Ware, C., Paulson, H.L. and Lieberman, A.P. (2010) Conditional Niemann-Pick C mice demonstrate cell autonomous Purkinje cell neurodegeneration. Hum. Mol. Genet., 19, 837-847.
23. Klein, A., Amigo, L., Retamal, M.J., Morales, M.G., Miquel, J.F., Rigotti, A. and Zanlungo, S. (2006) NPC2 is expressed in human and murine liver and secreted into bile: potential implications for body cholesterol homeostasis. Hepatology, 43, 126-133.
24. Blom, T.S., Linder, M.D., Snow, K., Pihko, H., Hess, M.W., Jokitalo, E., Veckman, V., Syvanen, A.C. and Ikonen, E. (2003) Defective endocytic trafficking of NPC1 and NPC2 underlying infantile Niemann-Pick type C disease. Hum. Mol. Genet., 12, 257-272.
25. Reddy, J.V., Ganley, I.G. and Pfeffer, S.R. (2006) Clues to neuro-degeneration in Niemann-Pick type C disease from global gene expression profiling. PLoS ONE, 1, e19.
26. Liao, G., Wen, Z., Irizarry, K., Huang, Y., Mitsouras, K., Darmani, M., Leon, T., Shi, L. and Bi, X. (2010) Abnormal gene expression in cerebellum of Npc1-/- mice during postnatal development. Brain Res., 1325, 128-140.
27. De Windt, A., Rai, M., Kytomaki, L., Thelen, K.M., Lutjohann, D., Bernier, L., Davignon, J., Soini, J., Pandolfo, M. and Laaksonen, R. (2007) Gene set enrichment analyses revealed several affected pathways in Niemann-pick disease type C fibroblasts. DNA Cell Biol., 26, 665-671.
28. Vazquez, M.C., Del Pozo, T., Robledo, F.A., Carrasco, G., Pavez, L., Olivares, F., Gonzalez, M. and Zanlungo, S. (2011) Alteration of gene expression profile in Niemann-Pick type C mice correlates with tissue damage and oxidative stress. PLoS ONE, 6, e28777.
29. Ramirez, C.M., Liu, B., Taylor, A.M., Repa, J.J., Burns, D.K., Weinberg, A.G., Turley, S.D. and Dietschy, J.M. (2010) Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life. Pediatr. Res., 68, 309-315.
30. Liu, B., Ramirez, C.M., Miller, A.M., Repa, J.J., Turley, S.D. and Dietschy, J.M. (2010) Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid. J. Lipid Res., 51, 933-944.
31. Liu, B., Turley, S.D., Burns, D.K., Miller, A.M., Repa, J.J. and Dietschy, J.M. (2009) Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse. Proc. Natl Acad. Sci. USA, 106, 2377-2382.
32. Repa, J.J., Li, H., Frank-Cannon, T.C., Valasek, M.A., Turley, S.D., Tansey, M.G. and Dietschy, J.M. (2007) Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse. J. Neurosci., 27, 14470-14480.
33. Chen, Y. and Goldstein, J.A. (2009) The transcriptional regulation of the human CYP2C genes. Curr. Drug Metab., 10, 567-578.
34. Wu, Y.P., Mizukami, H., Matsuda, J., Saito, Y., Proia, R.L. and Suzuki, K. (2005) Apoptosis accompanied by up-regulation of TNF-alpha death pathway genes in the brain of Niemann-Pick type C disease. Mol. Genet. Metab., 84, 9-17.
35. Klein, A., Maldonado, C., Vargas, L.M., Gonzalez, M., Robledo, F., Perez de Arce, K., Munoz, F.J., Hetz, C., Alvarez, A.R. and Zanlungo, S. (2011) Oxidative stress activates the c-Abl/p73 proapoptotic pathway in Niemann-Pick type C neurons. Neurobiol. Dis., 41, 209-218.
36. Fu, R., Yanjanin, N.M., Bianconi, S., Pavan, W.J. and Porter, F.D. (2010) Oxidative stress in Niemann-Pick disease, type C. Mol. Genet. Metab., 101, 214-218.
37. Rimkunas, V.M., Graham, M.J., Crooke, R.M. and Liscum, L. (2009) TNF-{alpha} plays a role in hepatocyte apoptosis in Niemann-Pick type C liver disease. J. Lipid Res., 50, 327-333.
38. Schaeffer, H.J. and Weber, M.J. (1999) Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol., 19, 2435-2444.
39. Weston, C.R. and Davis, R.J. (2007) The JNK signal transduction pathway. Curr. Opin. Cell Biol., 19, 142-149.
40. Kohyama, M., Ise, W., Edelson, B.T., Wilker, P.R., Hildner, K., Mejia, C., Frazier, W.A., Murphy, T.L. and Murphy, K.M. (2009) Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature, 457, 318-321.
41. Schweitzer, B.L., Huang, K.J., Kamath, M.B., Emelyanov, A.V., Birshtein, B.K. and DeKoter, R.P. (2006) Spi-C has opposing effects to PU.1 on gene expression in progenitor B cells. J. Immunol., 177, 2195-2207.
42. Numazaki, M., Tsutsumi, K., Tsutsumi, R. and Ishikawa, K. (1984) Expression of aldolase isozyme mRNAs in fetal rat liver. Eur. J. Biochem., 142, 165-170.
43. Reid, S. and Masters, C. (1985) On the ontogeny of aldolase isozymes and their interactions with cellular structure. Mech. Ageing Dev., 30, 299-317.
44. Hines, R.N. (2007) Ontogeny of human hepatic cytochromes P450. J. Biochem. Mol. Toxicol., 21, 169-175.
45. Hart, S.N., Cui, Y., Klaassen, C.D. and Zhong, X.B. (2009) Three patterns of cytochrome P450 gene expression during liver maturation in mice. Drug Metab. Dispos., 37, 116-121.
46. Herlong, J.L. and Scott, T.R. (2006) Positioning prostanoids of the D and J series in the immunopathogenic scheme. Immunol. Lett., 102, 121-131.
47. Nakamura, H., Yasufuku, K., Makiyama, T., Matsumoto, I., Fujino, H. and Murayama, T. (2011) Arachidonic acid metabolism via cytosolic phospholipase A(2) alpha induces cytotoxicity in Niemann-Pick disease type C cells. J. Cell. Physiol., 227, 2847-2855.
48. Huwiler, A. and Pfeilschifter, J. (2009) Lipids as targets for novel anti-inflammatory therapies. Pharmacol. Ther., 124, 96-112.
49. Kaspera, R. and Totah, R.A. (2009) Epoxyeicosatrienoic acids: formation, metabolism and potential role in tissue physiology and pathophysiology. Expert Opin. Drug Metab. Toxicol., 5, 757-771.
50. Node, K., Huo, Y., Ruan, X., Yang, B., Spiecker, M., Ley, K., Zeldin, D.C. and Liao, J.K. (1999) Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science, 285, 1276-1279.
51. Chen, Y., Zhang, Y., Yin, Y., Gao, G., Li, S., Jiang, Y., Gu, X. and Luo, J. (2005) SPD-a web-based secreted protein database. Nucleic Acids Res., 33, D169-D173.
52. Ertekin-Taner, N., Ronald, J., Feuk, L., Prince, J., Tucker, M., Younkin, L., Hella, M., Jain, S., Hackett, A., Scanlin, L. et al. (2005) Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene. Hum. Mol. Genet., 14, 447-460.
53. Finckh, U., van Hadeln, K., Muller-Thomsen, T., Alberici, A., Binetti, G., Hock, C., Nitsch, R.M., Stoppe, G., Reiss, J. and Gal, A. (2003) Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2. Neurogenetics, 4, 213-217.
54. Cataldo, A.M. and Nixon, R.A. (1990) Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proc. Natl Acad. Sci. USA, 87, 3861-3865.
55. Schwagerl, A.L., Mohan, P.S., Cataldo, A.M., Vonsattel, J.P., Kowall, N.W. and Nixon, R.A. (1995) Elevated levels of the endosomal-lysosomal proteinase cathepsin D in cerebrospinal fluid in Alzheimer disease. J. Neurochem., 64, 443-446.
56. Ladror, U.S., Snyder, S.W., Wang, G.T., Holzman, T.F. and Krafft, G.A. (1994) Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D. J. Biol. Chem., 269, 18422-18428.
57. Liu, F.T., Hsu, D.K., Zuberi, R.I., Kuwabara, I., Chi, E.Y. and Henderson, Jr W.R. (1995) Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am. J. Pathol., 147, 1016-1028.
58. Hsu, D.K., Dowling, C.A., Jeng, K.C., Chen, J.T., Yang, R.Y. and Liu, F.T. (1999) Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int. J. Cancer, 81, 519-526.
59. Henderson, N.C. and Sethi, T. (2009) The regulation of inflammation by galectin-3. Immunol. Rev., 230, 160-171.
60. Yanjanin, N.M., Velez, J.I., Gropman, A., King, K., Bianconi, S.E., Conley, S.K., Brewer, C.C., Solomon, B., Pavan, W.J., Arcos-Burgos, M. et al. (2010) Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C. Am. J. Med. Genet. B Neuropsychiatr. Genet., 153B, 132-140.
61. Patterson, M.C., Vecchio, D., Jacklin, E., Abel, L., Chadha-Boreham, H., Luzy, C., Giorgino, R. and Wraith, J.E. (2010) Long-term miglustat therapy in children with Niemann-Pick disease type C. J. Child Neurol., 25, 300-305.
62. Patterson, M.C., Vecchio, D., Prady, H., Abel, L. and Wraith, J.E. (2007) Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Lancet Neurol., 6, 765-772.
63. Pineda, M., Wraith, J.E., Mengel, E., Sedel, F., Hwu, W.L., Rohrbach, M., Bembi, B., Walterfang, M., Korenke, G.C., Marquardt, T. et al. (2009) Miglustat in patients with Niemann-Pick disease Type C (NP-C): a multicenter observational retrospective cohort study. Mol. Genet. Metab., 98, 243-249.
64. Wraith, J.E., Vecchio, D., Jacklin, E., Abel, L., Chadha-Boreham, H., Luzy, C., Giorgino, R. and Patterson, M.C. (2010) Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial. Mol. Genet. Metab., 99, 351-357.
65. Liu, B., Li, H., Repa, J.J., Turley, S.D. and Dietschy, J.M. (2008) Genetic variations and treatments that affect the lifespan of the NPC1 mouse. J. Lipid Res., 49, 663-669.
66. Davidson, C.D., Ali, N.F., Micsenyi, M.C., Stephney, G., Renault, S., Dobrenis, K., Ory, D.S., Vanier, M.T. and Walkley, S.U. (2009) Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. PLoS ONE, 4, e6951.
67. Aqul, A., Liu, B., Ramirez, C.M., Pieper, A.A., Estill, S.J., Burns, D.K., Repa, J.J., Turley, S.D. and Dietschy, J.M. (2011) Unesterified cholesterol accumulation in late endosomes/lysosomes causes neurodegeneration and is prevented by driving cholesterol export from this compartment. J. Neurosci., 31, 9404-9413.
68. Ward, S., O'Donnell, P., Fernandez, S. and Vite, C.H. (2010) 2-hydroxypropyl-beta-cyclodextrin raises hearing threshold in normal cats and in cats with Niemann-Pick type C disease. Pediatr. Res., 68, 52-56.
69. Wynn, T.A. (2008) Cellular and molecular mechanisms of fibrosis. J. Pathol., 214, 199-210.
70. Lee, J.M., Dedhar, S., Kalluri, R. and Thompson, E.W. (2006) The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol., 172, 973-981.
71. Rimkunas, V.M., Graham, M.J., Crooke, R.M. and Liscum, L. (2008) In vivo antisense oligonucleotide reduction of NPC1 expression as a novel mouse model for Niemann Pick type C- associated liver disease. Hepatology, 47, 1504-1512.
72. Somers, K.L., Brown, D.E., Fulton, R., Schultheiss, P.C., Hamar, D., Smith, M.O., Allison, R., Connally, H.E., Just, C., Mitchell, T.W. et al. (2001) Effects of dietary cholesterol restriction in a feline model of Niemann-Pick type C disease. J. Inherit. Metab. Dis., 24, 427-436.
73. Alvarez, A.R., Klein, A., Castro, J., Cancino, G.I., Amigo, J., Mosqueira, M., Vargas, L.M., Yevenes, L.F., Bronfman, F.C. and Zanlungo, S. (2008) Imatinib therapy blocks cerebellar apoptosis and improves neurological symptoms in a mouse model of Niemann-Pick type C disease. FASEB J., 22, 3617-3627.
74. Smith, D., Wallom, K.L., Williams, I.M., Jeyakumar, M. and Platt, F.M. (2009) Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1. Neurobiol. Dis., 36, 242-251.
75. Bascunan-Castillo, E.C., Erickson, R.P., Howison, C.M., Hunter, R.J., Heidenreich, R.H., Hicks, C., Trouard, T.P. and Gillies, R.J. (2004) Tamoxifen and vitamin E treatments delay symptoms in the mouse model of Niemann-Pick C. J. Appl. Genet., 45, 461-467.
76. Volk, B.W., Aronson, S.M. and Saifer, A. (1964) Fructose-1 phosphate aldolase deficiency in Tay-Sachs disease. Am. J. Med., 36, 481-484.
77. Dumic, J., Dabelic, S. and Flogel, M. (2006) Galectin-3: an open-ended story. Biochim. Biophys. Acta., 1760, 616-635.
78. Patterson, R.J., Wang, W. and Wang, J.L. (2004) Understanding the biochemical activities of galectin-1 and galectin-3 in the nucleus. Glycoconj. J., 19, 499-506.
79. Benes, P., Vetvicka, V. and Fusek, M. (2008) Cathepsin D-many functions of one aspartic protease. Crit. Rev. Oncol. Hematol., 68, 12-28.
80. Cataldo, A.M., Thayer, C.Y., Bird, E.D., Wheelock, T.R. and Nixon, R.A. (1990) Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin. Brain Res., 513, 181-192.
81. Zhou, W., Scott, S.A., Shelton, S.B. and Crutcher, K.A. (2006) Cathepsin D-mediated proteolysis of apolipoprotein E: possible role in Alzheimer's disease. Neuroscience, 143, 689-701.
82. Kenessey, A., Nacharaju, P., Ko, L.W. and Yen, S.H. (1997) Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration. J. Neurochem., 69, 2026-2038.
83. Amritraj, A., Peake, K., Kodam, A., Salio, C., Merighi, A., Vance, J.E. and Kar, S. (2009) Increased activity and altered subcellular distribution of lysosomal enzymes determine neuronal vulnerability in Niemann-Pick type C1-deficient mice. Am. J. Pathol., 175, 2540-2556.
84. Heinrich, M., Neumeyer, J., Jakob, M., Hallas, C., Tchikov, V., Winoto-Morbach, S., Wickel, M., Schneider-Brachert, W., Trauzold, A., Hethke, A. et al. (2004) Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death Differ., 11, 550-563.
85. Wang, M.D., Franklin, V., Sundaram, M., Kiss, R.S., Ho, K., Gallant, M. and Marcel, Y.L. (2007) Differential regulation of ATP binding cassette protein A1 expression and ApoA-I lipidation by Niemann-Pick type C1 in murine hepatocytes and macrophages. J. Biol. Chem., 282, 22525-22533.
86. Haidar, B., Kiss, R.S., Sarov-Blat, L., Brunet, R., Harder, C., McPherson, R. and Marcel, Y.L. (2006) Cathepsin D, a lysosomal protease, regulates ABCA1-mediated lipid efflux. J. Biol. Chem., 281, 39971-39981.
87. Vitner, E.B., Dekel, H., Zigdon, H., Shachar, T., Farfel-Becker, T., Eilam, R., Karlsson, S. and Futerman, A.H. (2010) Altered expression and distribution of cathepsins in neuronopathic forms of Gaucher disease and in other sphingolipidoses. Hum. Mol. Genet., 19, 3583-3590.
88. Loftus, S.K., Morris, J.A., Carstea, E.D., Gu, J.Z., Cummings, C., Brown, A., Ellison, J., Ohno, K., Rosenfeld, M.A., Tagle, D.A. et al. (1997) Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science, 277, 232-235.
89. Guo, L., Lobenhofer, E.K., Wang, C., Shippy, R., Harris, S.C., Zhang, L., Mei, N., Chen, T., Herman, D., Goodsaid, F.M. et al. (2006) Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat. Biotechnol., 24, 1162-1169.
90. Shi, L., Jones, W.D., Jensen, R.V., Harris, S.C., Perkins, R.G., Goodsaid, F.M., Guo, L., Croner, L.J., Boysen, C., Fang, H. et al. (2008) The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies. BMC Bioinformatics, 9 (Suppl. 9), S10.
91. Shi, L., Reid, L.H., Jones, W.D., Shippy, R., Warrington, J.A., Baker, S.C., Collins, P.J., de Longueville, F., Kawasaki, E.S., Lee, K.Y. et al. (2006) The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol., 24, 1151-1161.
92. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402-408.